Integra®

DEVICE3 trials

Sponsors

University Hospital, Bordeaux, Georgetown University, Hamilton Health Sciences Corporation

Conditions

Ankle InjuriesBurnsChronic WoundsFoot InjuriesLeg InjuriesNonmalignant ConditionWounds

Phase 1

A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells

Not yet recruitingNCT05344521

Hamilton Health Sciences CorporationBurns

Start: 2024-02-29End: 2027-02-28Target: 29Updated: 2023-12-15

Phase 3

Medico Economic Evaluation of Dermal Substitute Integra® for Coverage of Inferior Limb Traumatic Skin Loss

CompletedNCT00906672

University Hospital, BordeauxAnkle Injuries, Foot Injuries, Leg Injuries

Start: 2009-06-01End: 2014-01-01Updated: 2026-05-14

Unknown Phase

Comparing the Clinical Outcomes of DermACELL® With Integra® Bilayer Wound Matrix

Georgetown UniversityChronic Wounds, Nonmalignant Condition, Wounds

Start: 2014-04-18End: 2020-10-01Target: 53Updated: 2020-03-11